Neurocrine Biosciences (NBIX) Misses Q1 EPS by 5c

Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.49, $0.05 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $236.6 million versus the consensus estimate of $252.55 million.

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• VNET Group (VNET) Misses Q2 EPS by 164c
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance